Abiraterone Acetate

CAS 154229-18-2

Interested in hearing more about this API?

Abiraterone Acetate is used in the treatment of prostate cancer. It works by inhibiting CYP17, an enzyme critical to androgen production, thereby lowering testosterone levels that fuel cancer growth. It is typically administered with prednisone to manage side effects.

About the API

Technology

Synthetic

Therapeutic category

Oncology

Regulations
EU CEP
Korea DMF
Systematic Name

(3β)-17-(3-pyridinyl)androsta-5,16-dien-3-yl acetate

The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources. For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.

Contact us

Step 1 of

    First name*
    Last name*
    Business email*
    Company*
    Job title*
    Country*
    I'm interested in*
    Segment of interest*
    Tell us more about your project
    Select product*
    Formulation
    Project type*
    Target market
    Quantity
    Comments
    By clicking submit, you are agreeing to our Privacy Policy